The possibility of allogeneic placental therapy of postovariectomical manifestations in patients with gynecological cancer after antitumor treatment

The results of a clinical-psychological prospective examination of 131 patients with cervical cancer, the uterus body and ovaries of stage I-III according to FIGO, reproductive age in total hysterovectomy and radiation suppression of ovaries isolated in three clinical groups are presented: group I - patients after combined and complex special treatment; Group II - patients after combined radiation treatment and group III - patients after combined and complex treatment, therapy of postovariochemical manifestations of which was carried out by traditional therapy. Identification of personal resources of stress-resistance was carried out using the copy-test of R.Lazarus. The intensity of oxidative processes in blood plasma was judged by the content of their carbonyl derivatives, revealed in the reaction with 2,4-dinitrophenylhydrazine. Results and discussion. For patients in the state of total hysterovarioectomy (groups I and III), the hyperactivity of the strategy "Confrontation" (76.8% and 76.4%, respectively) and "Positive revaluation" (67.8% and 72.6%) are a common phenomenon. "Constructive strategies"; "Distant" (73.8%) and "Acceptance of responsibility" (82.5%) are typical for patients of the II group who are in drug and radiation suppression. In the blood of all patients, increased oxidative potential was determined. Significant changes were demonstrated in the analysis of the intensity of induced (metal-catalyzed) OMB: at λ 370 nm and λ 530 nm in group I and group III (p<0.01): the level of oxidation products was significantly lower in the group II patients after SLT. Changes were demonstrated in the analysis of the intensity of induced (metal-catalyzed) OMB. The level of carbonyl groups was significantly lower in the group of patients II after SLT (p<0.01). After the therapy with allogeneic hydrolyzate of the placenta (AHP) with Melsmon of the APEC for 14 weeks, an objective orientation toward a decrease in the oxidative potential in the blood of patients was manifested. The serum level of the end products of OMB had an active decrease in comparison with the similar values in group I at λ 370 nm (1.3 times) and λ 430 nm (1.5 times); p<0.01. At λ 530 nm - groups I decrease by 1.4 times and II decrease by 1.6 times, p<0.01. The level of OMB in induced oxidation demonstrated a pronounced active decrease, especially at λ 530 (p<0.01). The study of induced AMB in the serum of Group III patients with gynecological cancer, the treatment of which was carried out by traditional methods in the PES did not show any statistical differences. In group I patients, the activity of non-constructive strategies is significantly reduced: confrontation (from 76.8% to 54.2%); flight/avoidance (from 64.2% to 38.6%). More actively, patients began to apply resources to constructive distancing strategies (activity increased from 42.4% to 68.3%); planning of problem solving (from 42.8% to 72.4%). The active decrease in the level of the carbonyl products of protein oxidation correlated with the improvement and stabilization of the psychological status in the form of non-constructive coping strategies "Confrontation", "Escape-avoidance" in patients of group I (r=0.379, r=0.437, p<0.001) and group II (r=0.439, r=0.376, p<0.001). Conclusions. 1. In gynecological cancer cases examined in the PES state , there is an intensification of the processes of free radical oxidation of biomolecules. However, in patients with preserved ovaries, the oxidative processes are somewhat reduced. 2. Decrease in the levels of carbonyl oxidation products against the background of Melsmon therapy in patients with gynecological cancer in the state of PES testifies to the possibility of participation of the drug components in antiradical protection. 3. Evaluation of the results of sonographic monitoring of the abdominal and pelvic organs in patients included in the study did not reveal a worsening of the prognosis of the underlying disease against the background of allogeneic placental therapy. 4. Allogeneic placental therapy with Melsmon helps to improve the psychological status of gynecological cancer patients in the form of stress-overcoming.

postovarioectomic syndrome, gynecological cancer, coping behavior, oxidative stress